Literature DB >> 25441689

The fentanyl story.

Theodore H Stanley1.   

Abstract

Fentanyl, introduced more than 50 years ago, has become the most often used opioid for intraoperative analgesia. Since the early 1990s the fentanyl patch has been available for management of chronic pain of all forms of cancer as well as the persistent, intense pain from many noncancerous maladies. More than a half dozen rapid-onset transmucosal fentanyl preparations have been developed, approved, launched, and popularized for "breakthrough" pain syndromes in the past 20 years. The purpose of this article is to describe why this opioid has become so important in the treatment of pain in modern clinical practice. The data indicate that fentanyl's popularity has occurred because it has minimal cardiovascular effects, does not result in increases in plasma histamine, is relatively short in onset of action and duration of effect, is easy and inexpensive to synthesize and prepare for the marketplace, and is now familiar to clinicians working in pain and perioperative medicine throughout the world.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25441689     DOI: 10.1016/j.jpain.2014.08.010

Source DB:  PubMed          Journal:  J Pain        ISSN: 1526-5900            Impact factor:   5.820


  51 in total

1.  A Case Study Evaluating the Efficacy of an Ad Hoc Hospital Collection Device for Fentanyl in Infant Oral Fluid.

Authors:  Ashley M Gesseck; Justin L Poklis; Carl E Wolf; Jie Xu; Aamir Bashir; Karen D Hendricks-Muñoz; Michelle R Peace
Journal:  J Anal Toxicol       Date:  2020-10-12       Impact factor: 3.367

2.  Case Series: Rapid Induction Onto Long Acting Buprenorphine Injection for High Potency Synthetic Opioid Users.

Authors:  John J Mariani; Amy Mahony; Muhammad N Iqbal; Sean X Luo; Nasir H Naqvi; Frances R Levin
Journal:  Am J Addict       Date:  2020-03-13

Review 3.  Fentanyl Formulations in the Management of Pain: An Update.

Authors:  Stephan A Schug; Sonya Ting
Journal:  Drugs       Date:  2017-05       Impact factor: 9.546

4.  Fentanyl inhibits the progression of human gastric carcinoma MGC-803 cells by modulating NF-κB-dependent gene expression in vivo.

Authors:  Guodong He; L I Li; Enjian Guan; Jing Chen; Y I Qin; Yubo Xie
Journal:  Oncol Lett       Date:  2016-05-25       Impact factor: 2.967

5.  Canadian recommendations for the management of breakthrough cancer pain.

Authors:  P Daeninck; B Gagnon; R Gallagher; J D Henderson; Y Shir; C Zimmermann; B Lapointe
Journal:  Curr Oncol       Date:  2016-04-13       Impact factor: 3.677

Review 6.  Prevention and Treatment of Chronic Postsurgical Pain: A Narrative Review.

Authors:  Arnaud Steyaert; Patricia Lavand'homme
Journal:  Drugs       Date:  2018-03       Impact factor: 9.546

7.  Influence of St. John's Wort on Intravenous Fentanyl Pharmacokinetics, Pharmacodynamics, and Clinical Effects: A Randomized Clinical Trial.

Authors:  Michael J Loughren; Evan D Kharasch; Megan C Kelton-Rehkopf; Karen L Syrjala; Danny D Shen
Journal:  Anesthesiology       Date:  2020-03       Impact factor: 7.892

Review 8.  The DARK Side of Total Synthesis: Strategies and Tactics in Psychoactive Drug Production.

Authors:  Schuyler A Chambers; Jenna M DeSousa; Eric D Huseman; Steven D Townsend
Journal:  ACS Chem Neurosci       Date:  2018-02-01       Impact factor: 4.418

9.  A deadly trend in fentanyl fatalities (England, 1998-2017).

Authors:  Hugh Claridge; Bryn D Williams; Caroline S Copeland
Journal:  Br J Clin Pharmacol       Date:  2020-01-23       Impact factor: 4.335

10.  Opioid-like antinociceptive and locomotor effects of emerging fentanyl-related substances.

Authors:  Neil B Varshneya; D Matthew Walentiny; Lea T Moisa; Teneille D Walker; Luli R Akinfiresoye; Patrick M Beardsley
Journal:  Neuropharmacology       Date:  2019-03-20       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.